维普期刊资源整合服务平台（V6.5）

37篇 您的检索式：作者名="NADIMINTY N"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells 显示文摘	Lee S O Nadiminty N WU Xiu-xian	2005	Cancer Res2005，65，8：	1
2	Stat3 activation of NF - I kappa t B pl00 processing involves CBP/p300 - mediated acetylation 显示文摘	Nadiminty N Lou W Lee SO	2006	Proc Natl Acad Sci USA2006，103，79：	1
3	Stat3 activation of NF-{ kaPPa l B P100 processing involves CBP/P300- mediated aeetylation 显示文摘	Nadiminty N Lou W Lee S O	2006	Proc Natl Acad Sci USA2006，103，19：	1
4	Andrographolide, an herbal medicine, inhibits interleukin-6 expression and suppressespro-state cancer cell growth显示文摘	Chun JY Tummala R Nadiminty N	2010	Genes Cancer2010，1，8：	1
5	Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progres sion显示文摘	Lee SO Chun JY Nadiminty N	2007	Prostate2007，67，7：	1
6	Aberrant activation of the androgen receptor by NF-B2/p52 in prostate cancer cells 显示文摘	Nadiminty N Lou W Sun M	2010	Cancer Res2010，70，：	1
7	Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine dif- ferentiation to stimulator accompanied by androgen receptor activa- tion during LNCaP prostate cancer cell progression显示文摘	Lee S O Chun J Y Nadiminty N	2007	Prostate2007，67，7：	1
8	MicroRNA let-7 c isdownregulated in prostate cancer and suppresses prostate cancergrowth显示文摘	Nadiminty N Tummala R Lou W	2012	PLoS One2012，7，32：	1
9	Development of an androgen - dep rivation induced and androgen suppressed human prostate cancer cell line 显示文摘	Lee SO Dutt SS Nadiminty N	2007	Prostate2007，67，12：	1
10	Mechanisms of selenium down- regulation of androgen receptor signaling in prostate cancer显示文摘	Chun JY Nadiminty N Lee SO	2006	Mol Cancer Ther2006，5，：	1
11	NF-rB2/p52 induces resistance to enzalutamide in prostate cancer: role of androgen receptor and its variants 显示文摘	Nadiminty N Tummala R Liu C	2013	Mol Cancer Ther2013，12，：	1
12	Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion 显示文摘	Sun M Liu C Nadiminty N	2012	Prostate2012，72，1：	1
13	Inhibition of ABCB1 expression overcomes acquired docetaxel resistance in prostate cancer 显示文摘	Zhu Y Liu C Nadiminty N	2013	Mol Cancer Ther2013，12，9：	1
14	Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells显示文摘	Nadiminty N Lou W Sun M		0，，：	1
15	Eugenol Causes Melanoma Growth Suppression through Inhibition of E2F1 Transcriptional Activity显示文摘	GHOSH R NADIMINTY N FITZPATRICK J E	2005	J Biol Chem2005，280，7：	1
16	Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion 显示文摘	Sun M Liu C Nadiminty N	2012	Prostate2012，72，1：	1
17	Selenium disrupts estrogensignaling by altering estrogen receptor expression and ligand binding in human breast cancer cells显示文摘	Lee SO Nadiminty N Wu XX	2005	Cancer Res2005，4，：	1
18	Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression 显示文摘	LEE SO CHUN JY NADIMINTY N	2007	Prostate2007，67，7：	1
19	Interleukin-6undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression显示文摘	Lee S O Chun J Y Nadiminty N	2007	Prostate2007，67，7：	1
20	Interleukin-4 activates andro-genreceptor through CBP/p300显示文摘	Lee SO Chun JY Nadiminty N	2009	Prostate2009，69，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示